BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 11860358)

  • 1. Review of estrone sulfatase and its inhibitors--an important new target against hormone dependent breast cancer.
    Ahmed S; Owen CP; James K; Sampson L; Patel CK
    Curr Med Chem; 2002 Jan; 9(2):263-73. PubMed ID: 11860358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrone sulfatase and its inhibitors.
    Aidoo-Gyamfi K; Cartledge T; Shah K; Ahmed S
    Anticancer Agents Med Chem; 2009 Jul; 9(6):599-612. PubMed ID: 19601744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of (p-O-sulfamoyl)-N-alkanoyl-phenylalkyl amines as non-steroidal estrone sulfatase inhibitors.
    Kolli A; Chu GH; Rhodes ME; Inoue K; Selcer KW; Li PK
    J Steroid Biochem Mol Biol; 1999 Jan; 68(1-2):31-40. PubMed ID: 10215035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients.
    Nakata T; Takashima S; Shiotsu Y; Murakata C; Ishida H; Akinaga S; Li PK; Sasano H; Suzuki T; Saeki T
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):455-60. PubMed ID: 14623544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of potent non-estrogenic estrone sulfatase inhibitors.
    Li PK; Chu GH; Guo JP; Peters A; Selcer KW
    Steroids; 1998; 63(7-8):425-32. PubMed ID: 9654650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
    Pasqualini JR; Chetrite GS
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of placental estrone sulfatase activity and MCF-7 breast cancer cell proliferation by estrone-3-amino derivatives.
    Selcer KW; Jagannathan S; Rhodes ME; Li PK
    J Steroid Biochem Mol Biol; 1996 Sep; 59(1):83-91. PubMed ID: 9009241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of estrone sulfatase and proliferation of human breast cancer cells by nonsteroidal (p-O-sulfamoyl)-N-alkanoyl tyramines.
    Selcer KW; Hegde PV; Li PK
    Cancer Res; 1997 Feb; 57(4):702-7. PubMed ID: 9044848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid sulfatase: a new target for the endocrine therapy of breast cancer.
    Stanway SJ; Delavault P; Purohit A; Woo LW; Thurieau C; Potter BV; Reed MJ
    Oncologist; 2007 Apr; 12(4):370-4. PubMed ID: 17470679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers.
    Purohit A; Foster PA
    J Endocrinol; 2012 Feb; 212(2):99-110. PubMed ID: 21859802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroidal oxathiazine inhibitors of estrone sulfatase.
    Peters RH; Chao WR; Sato B; Shigeno K; Zaveri NT; Tanabe M
    Steroids; 2003 Jan; 68(1):97-110. PubMed ID: 12475726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dydrogesterone (Duphaston) and its 20-dihydro-derivative as selective estrogen enzyme modulators in human breast cancer cell lines. Effect on sulfatase and on 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity.
    Chetrite GS; Thole HH; Philippe JC; Pasqualini JR
    Anticancer Res; 2004; 24(3a):1433-8. PubMed ID: 15274306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid sulfatase inhibitors: promising new tools for breast cancer therapy?
    Geisler J; Sasano H; Chen S; Purohit A
    J Steroid Biochem Mol Biol; 2011 May; 125(1-2):39-45. PubMed ID: 21356310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of MCF-7 breast cancer cell proliferation by estrone sulfate and dehydroepiandrosterone sulfate: inhibition by novel non-steroidal steroid sulfatase inhibitors.
    Billich A; Nussbaumer P; Lehr P
    J Steroid Biochem Mol Biol; 2000; 73(5):225-35. PubMed ID: 11070351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways.
    Santen RJ; Leszczynski D; Tilson-Mallet N; Feil PD; Wright C; Manni A; Santner SJ
    Ann N Y Acad Sci; 1986; 464():126-37. PubMed ID: 3524346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid sulfatase: molecular biology, regulation, and inhibition.
    Reed MJ; Purohit A; Woo LW; Newman SP; Potter BV
    Endocr Rev; 2005 Apr; 26(2):171-202. PubMed ID: 15561802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
    Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
    J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent data on estrogen sulfatases and sulfotransferases activities in human breast cancer.
    Pasqualini JR; Schatz B; Varin C; Nguyen BL
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):323-9. PubMed ID: 1580921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent active site-directed inhibition of steroid sulphatase by tricyclic coumarin-based sulphamates.
    Woo LL; Purohit A; Malini B; Reed MJ; Potter BV
    Chem Biol; 2000 Oct; 7(10):773-91. PubMed ID: 11033081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and sulfatase inhibitory activities of non-steroidal estrone sulfatase inhibitors.
    Li PK; Milano S; Kluth L; Rhodes ME
    J Steroid Biochem Mol Biol; 1996 Sep; 59(1):41-8. PubMed ID: 9009236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.